ABT
35
-7
IRM
33
3
MU
42
-5
FLR
68
12
EXR
30
-5
DLTR
58
2
GWW
37
-2
BAC
57
6
PEP
60
21
MDLZ
59
9
PCAR
30
-4
ITW
50
10
PFG
56
3
DG
34
-6
HPQ
55
5
HP
33
3
GS
73
-2
EXPD
29
2
AKAM
37
2
PYPL
47
6
ABT
35
-7
IRM
33
3
MU
42
-5
FLR
68
12
EXR
30
-5
DLTR
58
2
GWW
37
-2
BAC
57
6
PEP
60
21
MDLZ
59
9
PCAR
30
-4
ITW
50
10
PFG
56
3
DG
34
-6
HPQ
55
5
HP
33
3
GS
73
-2
EXPD
29
2
AKAM
37
2
PYPL
47
6
Financhill
Back

Verve Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65

VERV
Verve Therapeutics

Last Price:
$10.96
Seasonality Move:
1.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Verve Therapeutics Stock Forecast

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 10% based on the past 4 years of stock performance.
  • Verve Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Verve Therapeutics Stock Undervalued?
    The current Verve Therapeutics [VERV] share price is $10.95. The Score for VERV is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • VERV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Verve Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 10% based on the past 4 years of stock performance.

Verve Therapeutics Stock Rating

Buy
65
Verve Therapeutics (VERV) is a Buy

Is Verve Therapeutics overpriced?

  • Verve Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Verve Therapeutics Stock Price History

Is VERV stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com

52-Week Data

52-Week High:
11.41
52-Week Low:
2.86

Prediction Charts

Market Cap:
976.1M
Price in USD:
10.95
Volume:
5.6M
Beta:
2.27

Technical Analysis

SMA50:
7.54
SMA100:
6.45
SMA200:
6.28
52-Wk Change:
45.81%

Stock Predictions

  • Is Verve Therapeutics stock public?
    Yes, Verve Therapeutics is a publicly traded company.
  • What is the Verve Therapeutics stock quote today?
    The Verve Therapeutics stock price is 10.95 USD today.
  • How to buy Verve Therapeutics stock online?
    You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-27 11.23 11.30 11.32 11.23
Jun-30 11.27 11.23 11.33 11.17
Jul-1 11.21 11.28 11.33 11.16
Jul-2 11.26 11.21 11.34 11.21
Jul-3 11.23 11.28 11.29 11.22
Jul-7 11.24 11.16 11.30 11.16
Jul-8 11.24 11.13 11.29 11.13
Jul-9 11.20 11.09 11.20 11.09
Jul-10 11.11 11.06 11.14 11.04
Jul-11 11.06 11.03 11.09 11.02
Jul-14 11.03 11.03 11.09 11.01
Jul-15 11.04 11.02 11.06 11.00
Jul-16 11.02 11.02 11.08 11.00
Jul-17 11.01 10.95 11.05 10.93

Verve Therapeutics Earnings

Verve Therapeutics Earnings Report: Per Share Verve Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Verve Therapeutics Forecast Revenue Growth

Verve Therapeutics Stock Analysis: Historical quarterly revenues per share for Verve Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.36 per share.

* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.